Purchase Order 75F40126P00307

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Lonza Walkersville, Inc. on August 3, 2026, for a Lonza 4D-Nucleofector Core Unit, X Unit, and associated warranty extensions, with a ceiling value of $26,097.00. Performance is at Lonza's Walkersville, Maryland facility with ultimate completion by November 3, 2026. The order is firm fixed price with no set-aside applied. The 4D-Nucleofector systems are specialized transfection devices used in cell-based...

The Food and Drug Administration awarded a purchase order to Lonza Walkersville, Inc. for a 4D nucleofection system valued at $24,329.00 on August 17, 2026, with a completion date of December 15, 2026. The system will be installed at FDA/CBER in Silver Spring, Maryland. The equipment is designed to deliver DNA, RNA, and proteins into cell lines (HEK293, CHO, Huh7) and human primary cells using conductive polymer electrodes, process 2104 to 1107 cells per reaction, achieve post-transfection...

<p>The National Institute of Child Health and Human Development awarded a firm fixed-price purchase order to Lonza Walkersville, Inc. for a 4D-Nucleofector Core Unit and related parts in the amount of $19,129.25, with an award date of June 25, 2021 and ultimate completion date of September 30, 2021. Place of performance is Bethesda, Maryland. The order references quote 20133944/3 and carries no set-aside designation.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Lonza Walkersville, Inc. for a 4D-Nucleofector on November 16, 2016, with a ceiling value of $15,726.09. Performance is located in Bethesda, Maryland, and the order is due for completion on November 15, 2017. The purchase order is for firm fixed price commercial equipment.</p>

This federal contract award, with an ID of 12305B21P0230, was issued by the Northeast Area of a civilian federal agency to Lonza Walkersville, Inc., a foreign-owned, for-profit manufacturer of biological materials, laboratory equipment, and scientific services. The $19,129.24 firm fixed-price purchase order is for the supply of &quot;4D NUCLEOFECTOR FROM LONZA&quot;, a specialized transfection device. The award is not associated with a set-aside program. Lonza Walkersville has a significant...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Lonza Walkersville, Inc. for 96 well shuttle transfection devices valued at $23,456.00, with an award date of November 27, 2018 and ultimate completion date of November 26, 2019. No set-aside was used. Performance takes place in Walkersville, Maryland. The order procures specialized laboratory transfection equipment supplied as a commercial item under firm fixed-price terms.</p>

The National Institutes of Health Clinical Center awarded a purchase order to Lonza Walkersville, Inc. valued at $20,966.00 on August 21, 2018, with ultimate completion on August 20, 2019. The award carries no set-aside designation and is structured as a firm fixed-price purchase order for commercial items. Work is performed at Lonza Walkersville's Walkersville, Maryland facility. The order procures biological materials, cell culture media, and specialized laboratory equipment typical of Lonza's...

Lonza Walkersville, Inc., a foreign-owned manufacturer of biological materials and laboratory equipment headquartered in Maryland, received a task order award valued at $10,724.64 under a Blanket Purchase Agreement (BPA) with the Department of Health and Human Services Office of the Director. This firm-fixed-price call order, issued on August 14, 2012, with an ultimate completion date of December 31, 2012, pertains to drugs and biologicals and represents work performed at Lonza's Walkersville,...

<p>The Food and Drug Administration awarded a purchase order to Lonza Walkersville, Inc. for $47,660.83 on August 24, 2023, for absorbance/fluorescence multimode microplate reader installation qualification (IQ/OQ/PQ) for endotoxins testing. Work is performed at Lonza's Walkersville, Maryland facility. The order carries a firm fixed price and completed by November 22, 2023. The underlying solicitation was posted June 23, 2023, with a due date of June 30, 2023.</p>

<p>The NIH Clinical Center awarded a purchase order to Lonza Walkersville, Inc. valued at $42,500 on January 3, 2019, under firm fixed-price terms with no set-aside designation. Performance occurs in Walkersville, Maryland, with an ultimate completion date of December 31, 2019. The source does not specify the items or services being procured.</p>